N 739 150 (Mexiletine 150 mg)

Pill with imprint N 739 150 is Tan / Orange, Capsule-shape and has been identified as Mexiletine hydrochloride 150 mg. It is supplied by Teva Pharmaceuticals USA.

Mexiletine is used in the treatment of diabetic peripheral neuropathy; ventricular tachycardia; myotonia congenita; arrhythmia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Mexiletine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for N 739 150

Mexiletine hydrochloride

Imprint:

N 739 150

Strength:

150 mg

Color:

Tan / Orange

Size:

18.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Group I antiarrhythmics

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Teva Pharmaceuticals USA

Inactive Ingredients:

silicon dioxide
magnesium stearate
corn starch
FD&C Yellow No. 6
gelatin
titanium dioxide
D&C Red No. 28
FD&C Blue No. 1
ammonia
ferrosoferric oxide
D&C Yellow No. 10
alcohol
FD&C Blue No. 2
FD&C Red No. 40
isopropyl alcohol
butyl alcohol
propylene glycol
shellac
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC Code	Labeler / Repackager
42291-0624	AvKare, Inc.
49999-0916	Lake Erie Medical and Surgical Supply (repackager)

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.